LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma

Photo from wikipedia

Pulmonary sarcomatoid carcinoma (PSC) is a poorly differentiated non‐small‐cell lung carcinoma (NSCLC) with aggressive behaviour. This study aimed to evaluate the prognostic clinicopathological and genetic characteristics of PSCs. Click to show full abstract

Pulmonary sarcomatoid carcinoma (PSC) is a poorly differentiated non‐small‐cell lung carcinoma (NSCLC) with aggressive behaviour. This study aimed to evaluate the prognostic clinicopathological and genetic characteristics of PSCs.

Keywords: kras mutation; carcinoma; mutation predictive; predictive outcome; pulmonary sarcomatoid; sarcomatoid carcinoma

Journal Title: Histopathology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.